Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Frazee

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Medicinal Chemistry|February 1, 1973
3-Phenyl-5-quinolinemethanol antimalarialsA Makriyannis, J S Frazee, J W Wilson
Journal of Medicinal Chemistry|October 1, 1977
Adrenerigic agents. 7.1 Synthesis and beta-adrenergic agonist activity of several 2-pyridylethanolaminesT Jen, J S Frazee, M S Schwartz, et al.
Journal of Medicinal Chemistry|August 1, 1977
Adrenergic agents. 6. Synthesis and potential beta-adrenergic agonist activity of some meta-substituted p-hydroxyphenylethanolamines related to salbutamolT Jen, J S Frazee, C Kaiser, et al.
Journal of Medicinal Chemistry|October 1, 1977
Adrenergic agents. 8.1 Synthesis and beta-adrenergic agonist activity of some 3-tert-butylamino-2-(substituted phenyl)-1-propanolsT Jen, J S Frazee, M S Schwartz, et al.
Journal of Medicinal Chemistry|June 1, 1986
Substituted 1-benzylimidazole-2-thiols as potent and orally active inhibitors of dopamine beta-hydroxylaseL I Kruse, C Kaiser, W E DeWolf, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 1994
SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonistE H Ohlstein, P Nambi, S A Douglas, et al.
Journal of Medicinal Chemistry|February 1, 1990
Some benzyl-substituted imidazoles, triazoles, tetrazoles, pyridinethiones, and structural relatives as multisubstrate inhibitors of dopamine beta-hydroxylase. 4. Structure-activity relationships at the copper binding siteL I Kruse, C Kaiser, W E DeWolf, et al.
Journal of Medicinal Chemistry|March 1, 1987
Multisubstrate inhibitors of dopamine beta-hydroxylase. 2. Structure-activity relationships at the phenethylamine binding siteL I Kruse, C Kaiser, W E DeWolf, et al.
Journal of Medicinal Chemistry|May 1, 1985
Orally active and potent inhibitors of gamma-aminobutyric acid uptakeF E Ali, W E Bondinell, P A Dandridge, et al.
Drug Metabolism Reviews|January 1, 1983
Inhibitors of phenylethanolamine N-methyltransferase and epinephrine biosynthesis: a potential source of new drugsW E Bondinell, F W Chapin, J S Frazee, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Medicinal Chemistry|February 1, 1973
3-Phenyl-5-quinolinemethanol antimalarialsA Makriyannis, J S Frazee, J W Wilson
Journal of Medicinal Chemistry|October 1, 1977
Adrenerigic agents. 7.1 Synthesis and beta-adrenergic agonist activity of several 2-pyridylethanolaminesT Jen, J S Frazee, M S Schwartz, et al.
Journal of Medicinal Chemistry|August 1, 1977
Adrenergic agents. 6. Synthesis and potential beta-adrenergic agonist activity of some meta-substituted p-hydroxyphenylethanolamines related to salbutamolT Jen, J S Frazee, C Kaiser, et al.
Journal of Medicinal Chemistry|October 1, 1977
Adrenergic agents. 8.1 Synthesis and beta-adrenergic agonist activity of some 3-tert-butylamino-2-(substituted phenyl)-1-propanolsT Jen, J S Frazee, M S Schwartz, et al.
Journal of Medicinal Chemistry|June 1, 1986
Substituted 1-benzylimidazole-2-thiols as potent and orally active inhibitors of dopamine beta-hydroxylaseL I Kruse, C Kaiser, W E DeWolf, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 1994
SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonistE H Ohlstein, P Nambi, S A Douglas, et al.
Journal of Medicinal Chemistry|February 1, 1990
Some benzyl-substituted imidazoles, triazoles, tetrazoles, pyridinethiones, and structural relatives as multisubstrate inhibitors of dopamine beta-hydroxylase. 4. Structure-activity relationships at the copper binding siteL I Kruse, C Kaiser, W E DeWolf, et al.
Journal of Medicinal Chemistry|March 1, 1987
Multisubstrate inhibitors of dopamine beta-hydroxylase. 2. Structure-activity relationships at the phenethylamine binding siteL I Kruse, C Kaiser, W E DeWolf, et al.
Journal of Medicinal Chemistry|May 1, 1985
Orally active and potent inhibitors of gamma-aminobutyric acid uptakeF E Ali, W E Bondinell, P A Dandridge, et al.
Drug Metabolism Reviews|January 1, 1983
Inhibitors of phenylethanolamine N-methyltransferase and epinephrine biosynthesis: a potential source of new drugsW E Bondinell, F W Chapin, J S Frazee, et al.
Pageof 2